BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 18491681)

  • 1. Urinary and rectal incontinence during gabapentin therapy.
    Iyer R; Egloff L; Fraas J; Harris JD
    J Support Oncol; 2008 Apr; 6(4):152. PubMed ID: 18491681
    [No Abstract]   [Full Text] [Related]  

  • 2. Incontinence during treatment with gabapentin.
    Gil-Nagel A; Gapany S; Blesi K; Villanueva N; Bergen D
    Neurology; 1997 May; 48(5):1467-8. PubMed ID: 9153498
    [No Abstract]   [Full Text] [Related]  

  • 3. Neutropenia occurring after starting gabapentin for neuropathic pain.
    Derbyshire E; Martin D
    Clin Oncol (R Coll Radiol); 2004 Dec; 16(8):575-6. PubMed ID: 15630852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Myoclonias secondary to gabapentin in a patient with chronic renal failure].
    Prieto-Pérez L; Montastruc J; García-Ruiz PJ
    Rev Neurol; 2011 Apr; 52(8):512. PubMed ID: 21425106
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapeutic drug monitoring of gabapentin].
    Tribut O; Bentué-Ferrer D; Verdier MC;
    Therapie; 2010; 65(1):57-60. PubMed ID: 20205997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral fixed drug eruption caused by gabapentin.
    Gupta S; Gupta S; Mittal A; David S
    J Eur Acad Dermatol Venereol; 2009 Oct; 23(10):1207-8. PubMed ID: 19250328
    [No Abstract]   [Full Text] [Related]  

  • 7. Life-threatening status epilepticus following gabapentin administration in a patient with benign adult familial myoclonic epilepsy.
    Striano P; Coppola A; Madia F; Pezzella M; Ciampa C; Zara F; Striano S
    Epilepsia; 2007 Oct; 48(10):1995-8. PubMed ID: 17645541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gabapentin toxicity in renal failure: the importance of dose adjustment.
    Miller A; Price G
    Pain Med; 2009 Jan; 10(1):190-2. PubMed ID: 18721173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy of gabapentin in migraine prophylaxis: an observational open label study.
    Vuković V; Lovrencić-Huzjan A; Bosnar-Puretić M; Demarin V
    Acta Clin Croat; 2009 Jun; 48(2):145-51. PubMed ID: 19928412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Six cases of (severe) hypoglycaemia associated with gabapentin use in both diabetic and non-diabetic patients.
    Scholl JH; van Eekeren R; van Puijenbroek EP
    Br J Clin Pharmacol; 2015 May; 79(5):870-1. PubMed ID: 25387462
    [No Abstract]   [Full Text] [Related]  

  • 11. Dyskinesia induced by gabapentin in idiopathic Parkinson's disease.
    Raju PM; Walker RW; Lee MA
    Mov Disord; 2007 Jan; 22(2):288-9. PubMed ID: 17089397
    [No Abstract]   [Full Text] [Related]  

  • 12. Gabapentin withdrawal: case report in an older adult and review of the literature.
    Mah L; Hart M
    J Am Geriatr Soc; 2013 Sep; 61(9):1635-7. PubMed ID: 24028370
    [No Abstract]   [Full Text] [Related]  

  • 13. [A novel antiepileptic, gabapentin (GABAPEN)].
    Kunihara M; Sase S; Arakawa A
    Nihon Yakurigaku Zasshi; 2007 Apr; 129(4):299-307. PubMed ID: 17435343
    [No Abstract]   [Full Text] [Related]  

  • 14. [Drug-induced hypersensitivity syndrome due to gabapentin].
    Goldman J; Duval-Modeste AB; Musette P; Joly P; Massy N; Courville C; Rabehenoina A
    Ann Dermatol Venereol; 2008 Mar; 135(3):230-2. PubMed ID: 18374860
    [No Abstract]   [Full Text] [Related]  

  • 15. Asterixis related to gabapentin intake: a case report and review.
    Wahba M; Waln O
    Postgrad Med; 2013 Sep; 125(5):139-41. PubMed ID: 24113672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gabapentin-induced rhabdomyolysis in a patient with diabetic neuropathy.
    Bilgir O; Calan M; Bilgir F; Kebapçilar L; Yüksel A; Yildiz Y; Sari I
    Intern Med; 2009; 48(12):1085-7. PubMed ID: 19525604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probability of rash related to gabapentin therapy in a child.
    Gijsen VM; de Wildt SN; Ito S
    Ann Pharmacother; 2009 Feb; 43(2):387-9. PubMed ID: 19193587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gabapentin treatment of neurogenic overactive bladder.
    Carbone A; Palleschi G; Conte A; Bova G; Iacovelli E; Bettolo CM; Pastore A; Inghilleri M
    Clin Neuropharmacol; 2006; 29(4):206-14. PubMed ID: 16855422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-blind evaluation of gabapentin on alcohol effects and drinking in a clinical laboratory paradigm.
    Myrick H; Anton R; Voronin K; Wang W; Henderson S
    Alcohol Clin Exp Res; 2007 Feb; 31(2):221-7. PubMed ID: 17250613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Gabapentin abuse].
    Mondón S; Nogué S; Urbano D; Rovira E
    Med Clin (Barc); 2010 Feb; 134(3):138-9. PubMed ID: 19361820
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.